Wikisage, the free encyclopedia of the second generation, is digital heritage
Lorazepam: Difference between revisions
Jump to navigation
Jump to search
m (→Propofol) |
|||
| Line 14: | Line 14: | ||
[[Midazolam]] (or lorazepam i.v.) controls effectively 63-73% early SE<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559580/pdf/40265_2015_Article_454.pdf Pharmacotherapy for Status Epilepticus]</ref> | [[Midazolam]] (or lorazepam i.v.) controls effectively 63-73% early SE<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559580/pdf/40265_2015_Article_454.pdf Pharmacotherapy for Status Epilepticus]</ref> | ||
==clonazepam== | |||
more lipophylic that lorazepam, but less lipophilic than diazepam(Congdon et Forsythe epilepsia 21:97(1980)) | |||
==Levetirazetam== | ==Levetirazetam== | ||
Revision as of 23:59, 25 January 2016
sufficient lengh of time (viewed as 30 min.period)
Status epilepticus, ILAe view as a seizure that persists for a sufficient lengh of time, maybe 5-10 (focal) minutes.
[1]
diazepam
intravenous
Other agents
lorazepam>phenitoin
midazolam
Midazolam (or lorazepam i.v.) controls effectively 63-73% early SE[2]
clonazepam
more lipophylic that lorazepam, but less lipophilic than diazepam(Congdon et Forsythe epilepsia 21:97(1980))
Levetirazetam
comparison
Propofol
recruitment problem
see also Trinka et al 2015 Pharmacotherapy for Status Epilepticus Drugs 1491-1521.